KeyBank National Association’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.01M | Sell |
|
|||||
|
2025
Q2 | $1.54M | Sell |
|
|||||
|
2025
Q1 | $3.37M | Sell |
|
|||||
|
2024
Q4 | $4.57M | Sell |
|
|||||
|
2024
Q3 | $11.4M | Sell |
|
|||||
|
2024
Q2 | $33.4M | Sell |
|
|||||
|
2024
Q1 | $49M | Sell |
|
|||||
|
2023
Q4 | $59.9M | Buy |
|
|||||
|
2023
Q3 | $54.1M | Buy |
|
|||||
|
2023
Q2 | $51.1M | Buy |
|
|||||
|
2023
Q1 | $54.6M | Buy |
|
|||||
|
2022
Q4 | $55.2M | Buy |
|
|||||
|
2022
Q3 | $42.3M | Buy |
|
|||||
|
2022
Q2 | $39M | Buy |
|
|||||
|
2022
Q1 | $29.4M | Buy |
|
|||||
|
2021
Q4 | $26.9M | Buy |
|
|||||
|
2021
Q3 | $13.9M | Buy |
|
|||||
|
2021
Q2 | $14.7M | Buy |
|
|||||
|
2021
Q1 | $12.1M | Buy |
|
|||||
|
2020
Q4 | $5.74M | Buy |
|
|||||
|
2020
Q3 | $909K | Buy |
|
|||||
|
2020
Q2 | $1.23M | Buy |
|
|||||
|
2020
Q1 | $689K | Sell |
|
|||||
|
2019
Q4 | $820K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $322K | Sell |
|
|||||
|
2019
Q1 | $572K | Sell |
|
|||||
|
2018
Q4 | $614K | Buy |
|
|||||
|
2018
Q3 | $541K | Sell |
|
|||||
|
2018
Q2 | $1.01M | Buy |
|
|||||
|
2018
Q1 | $396K | Sell |
|
|||||
|
2017
Q4 | $554K | Sell |
|
|||||
|
2017
Q3 | $727K | Buy |
|
|||||
|
2017
Q2 | $451K | Sell |
|
|||||
|
2017
Q1 | $682K | Buy |
|
|||||
|
2016
Q4 | $487K | Buy |
|
|||||
|
2016
Q3 | $397K | Sell |
|
|||||
|
2016
Q2 | $403K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $482K | Buy |
|
|||||
|
2015
Q3 | $262K | Sell |
|
|||||
|
2015
Q2 | $824K | Sell |
|
|||||
|
2015
Q1 | $775K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $442K | Buy |
|
|||||
|
2014
Q1 | $374K | Sell |
|
|||||
|
2013
Q4 | $415K | Buy |
|
|||||
|
2013
Q3 | $390K | Sell |
|
|||||
|
2013
Q2 | $351K | Buy |
|